Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04847700
Other study ID # MD.21.02.418.R1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date June 1, 2023

Study information

Verified date July 2021
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The distinctive symptoms of Meniere's disease (MD) include recurrent vertigo spells, fluctuating hearing loss, aural fullness and tinnitus. Conservative treatment in MD comprises lifestyle modifications, such as low-sodium diet, avoidance of caffeine, alcohol and stress, in addition to medication such as diuretics and betahistine. When conservative treatment fails, surgical management is attempted. Surgical interventions comprise transtympanic steroids or gentamicin, endolymphatic sac surgery (ES), ventilation tube placement, vestibular neurectomy, and labyrinthectomy. Recently, Loader et al. have presented encouraging results of the effectiveness of tenotomy of the stapedius and tensor tympani muscles (TSTM) in the management of patients with definite MD. Also, satisfactory results were obtained with endoscopic assisted minimally invasive vestibular neurectomy (MIVN). The aim of this study is to compare the clinical outcomes of MD patients who were submitted to either MIVN or TSTM in our department.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 1, 2023
Est. primary completion date January 1, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - unilateral definite Meniere's disease. Exclusion Criteria: - other peripheral or central vestibular disorders, bilateral MD and neurologic disorders. - Previous history of chronic otitis media or middle ear surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Surgical treatment
Endoscopic retrosigmoid minimally invasive vestibular neurectomy
Surgical treatment
Endoscopic tenotomy of middle ear muscles

Locations

Country Name City State
Egypt ORL-HNS department,Mansoura University Hospital, Faculty of Medicine, Mansoura University Mansoura ElDakahlia

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary dizziness handicap inventory (DHI) contains 25 questions divided into physical, emotional, and functional subgroups. Each question is to be answered using a scale with ''no'' (0 points), ''sometimes'' (2 points), or ''yes'' (4 points). The total score ranges from zero (no incapacity) to 100 (severe incapacity). 6 months after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04677972 - SPI-1005 for the Treatment of Meniere's Disease Phase 3
Recruiting NCT05582837 - Treatment of Meniere's Disease With Migraine Medications Phase 4